Showing results (381-390 of 414) with videos related to
Sort By:
Pageof 42
Current Problems in Cancer|August 1, 1981
Biologic markers in cancer diagnosis and treatmentE D Holyoke, G E Block, E Jensen, et al.Cancer|November 14, 1997
Observations on the early detection of prostate cancer from the American Cancer Society National Prostate Cancer Detection ProjectC J Mettlin, G P Murphy, R J Babaian, et al.International Journal of Cancer|May 16, 1997
Isolation and characterization of a novel gene from human glioblastoma multiforme tumor tissueA Sehgal, C Keener, A L Boynton, et al.Investigative Radiology|November 1, 1980
synthesis and biological testing of nonionic iodinated x-ray contrast mediaG B Hoey, R M Hopkins, K R Smith, et al.Journal of Surgical Oncology|February 1, 1997
Characterization of C4-2 as a tumor-suppressor gene in human brain tumorsA Sehgal, C Keener, A L Boynton, et al.The Prostate|May 6, 1998
Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)M L Salgaller, P A Lodge, J G McLean, et al.Radiology|January 1, 1986
Prostatic evaluation by transrectal sonography: criteria for diagnosis of early carcinomaF Lee, J M Gray, R D McLeary, et al.Cancer Research|February 1, 1985
Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancerC S Killian, N Yang, L J Emrich, et al.The Prostate|September 1, 1997
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptidesB A Tjoa, S J Erickson, V A Bowes, et al.The Prostate|October 8, 1997
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancerG P Murphy, M J Troychak, O E Cobb, et al.Pageof 42